This report presents the 2011 update to the American Brachytherapy Society (ABS) high-dose-rate (HDR) brachytherapy guidelines for locally advanced cervical cancer
Background: Incidence and mortality estimates are used to measure the burden of cancer in a populati...
INTRODUCTION: Carcinoma of the uterine cervix is the second most common cancer among global women a...
Purpose: In radical radiotherapy for cervical cancer, high-dose-rate (HDR) brachytherapy is commonl...
This report presents the 2011 update to the American Brachytherapy Society (ABS) high-dose-rate (HDR...
To determine the acute vaginal mucosal toxicity and clinical response of cervical cancer after defin...
Item does not contain fulltextBACKGROUND AND PURPOSE: In order to meet the deficiencies of endocavit...
AbstractPurposeThis study aims to report the incidence of treatment-induced acute toxicities, local ...
"nBackground: Treatment of cervical carcinoma is routinely performed with Low Dose Rate (LDR) b...
Background: Carcinoma cervix is one of the two most common cancers of Indian women with very high mo...
Traditionally, cervical brachytherapy has been prescribed to point A. However, since the Groupe Euro...
The treatment of advanced cervical cancer patients consists of chemo-radiation and brachytherapy. Af...
Abstract Background The literature supporting high-dose rate brachytherapy (HDR) in the treatment of...
Purpose:The aims of this study were to investigate the clinical feasibility and to report our prelim...
BACKGROUND: Traditionally, low dose rate (LDR) brachytherapy has been used as a standard modality in...
Purpose: To develop and evaluate a fast, automated multi-criterial treatment planning approach for a...
Background: Incidence and mortality estimates are used to measure the burden of cancer in a populati...
INTRODUCTION: Carcinoma of the uterine cervix is the second most common cancer among global women a...
Purpose: In radical radiotherapy for cervical cancer, high-dose-rate (HDR) brachytherapy is commonl...
This report presents the 2011 update to the American Brachytherapy Society (ABS) high-dose-rate (HDR...
To determine the acute vaginal mucosal toxicity and clinical response of cervical cancer after defin...
Item does not contain fulltextBACKGROUND AND PURPOSE: In order to meet the deficiencies of endocavit...
AbstractPurposeThis study aims to report the incidence of treatment-induced acute toxicities, local ...
"nBackground: Treatment of cervical carcinoma is routinely performed with Low Dose Rate (LDR) b...
Background: Carcinoma cervix is one of the two most common cancers of Indian women with very high mo...
Traditionally, cervical brachytherapy has been prescribed to point A. However, since the Groupe Euro...
The treatment of advanced cervical cancer patients consists of chemo-radiation and brachytherapy. Af...
Abstract Background The literature supporting high-dose rate brachytherapy (HDR) in the treatment of...
Purpose:The aims of this study were to investigate the clinical feasibility and to report our prelim...
BACKGROUND: Traditionally, low dose rate (LDR) brachytherapy has been used as a standard modality in...
Purpose: To develop and evaluate a fast, automated multi-criterial treatment planning approach for a...
Background: Incidence and mortality estimates are used to measure the burden of cancer in a populati...
INTRODUCTION: Carcinoma of the uterine cervix is the second most common cancer among global women a...
Purpose: In radical radiotherapy for cervical cancer, high-dose-rate (HDR) brachytherapy is commonl...